Skip to main content

Table 1 Demographic and clinical data of HC, MS and NMO

From: Increased plasma levels of epithelial neutrophil-activating peptide 78/CXCL5 during the remission of Neuromyelitis optica

  

HC (n = 20)

MS (n = 25)

NMO (n = 25)

Gender

F/M

15/5

19/6

23/2

Age (year)

Range

25–54

16–59

14–55

 

Mean ± SE

32.30 ± 1.80

33.84 ± 2.31

36.80 ± 2.45

Age at onset (year)

Range

-

6–57

13–53

 

Mean ± SE

-

29.84 ± 2.28

30.24 ± 2.34

Disease duration (year)

Range

-

0–12

0–21

 

Mean ± SE

-

3.92 ± 0.53

6.04 ± 1.01

ARR

Range

-

0.35–12.00

0.01–12.00

 

Mean ± SE

-

1.61 ± 0.47

1.69 ± 0.47

EDSS

Range

-

0–3.5

1–6.5

 

Mean ± SE

-

1.92 ± 0.28

3.24 ± 0.35*

  1. HC healthy controls, MS multiple sclerosis, NMO Neuromyelitis optica, EDSS expanded disability status scale, ARR annual relapse rate
  2. *P < 0.05
Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us